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Abstract
Synovial sarcomas of the prostate are exceedingly rare malignant tumors. Only a few cases have been
reported so far. We discuss a case of a 52-year-old male who presented with signs and symptoms of benign
prostate hyperplasia (BPH) and was diagnosed with synovial sarcoma of the prostate. Since this sarcoma is
rare, it can easily be misdiagnosed with BPH or adenocarcinoma of the prostate.
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Introduction
Leiomyosarcoma is the most common type of soft tissue sarcoma. Soft tissue sarcoma is a soft tissue
carcinoma primarily seen in young adults in the para-articular region of the extremities. It can also present
in unusual sites like the orofacial or oropharyngeal region, larynx, esophagus, lung, heart, abdominal wall,
gastrointestinal tract, and retroperitoneum [1-2]. Several sarcomas have previously been described in the
prostate, including fibrosarcoma, rhabdomyosarcoma, leiomyosarcoma, and stromal sarcoma. However,
synovial sarcoma in the prostate is extremely rare. Only seven previously reported cases have been published
[3-8].

Case Presentation
A 52-year-old male patient with past medical history significant for nephrolithiasis and gout, who initially
presented to the emergency department with the complaint of progressively worsening urinary retention,
started as difficulty initiating urination and later developed complete urinary retention over several months.
In the ED, a CT abdomen/pelvis contrast scan was performed, demonstrating enlarged prostate (9.6cm) with
a mass effect on the rectum and bladder (Figure 1). A foley catheter was inserted, and the patient was
discharged from ED to follow up with urology as an outpatient. A transrectal ultrasound (TRUS)-guided
biopsy was performed, which demonstrated spindle cell malignancy with immunostaining positive for TLE1
gene and negative for CD117, CD34, progesterone receptors (PR), desmin, SOX10, STAT6, pan-cytokeratin,
and AE1/AE3. An MRI of the pelvis showed a large heterogeneous partially necrotic mass arising from the
left prostate, invading the rectal wall, suspicious for prostatic sarcoma (Figure 2). A positron emission
tomography (PET) showed 7.2 x 7.6 cm heterogeneously markedly fluorodeoxyglucose (FDG)-avid necrotic
mass with areas of hemorrhage encompassing the entire prostate. Mildly avid FDG uptake in left external
iliac lymph node and left common iliac lymph node was noted on PET scan, concerning the local nodal
metastatic disease (Figure 3).
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FIGURE 1: Axial CT pelvis showing enlarged prostate (9.6cm) (red
arrow) with a mass effect on the rectum and bladder

FIGURE 2: Axial MRI T2 showing heterogeneous necrotic mass arising
from the left prostate (red arrow), invading the rectal wall
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FIGURE 3: (A) FDG PET MIP showing heterogeneous FDG uptake in the
prostate gland in addition to the physiologic distribution of the
radiotracer; (B) Axial non-contrast CT showing heterogeneously
enlarged prostate gland with interspersed areas of necrosis; (C) Axial
FDG PET showing heterogeneous FDG uptake in the enlarged prostate
gland; (D) Fused FDG PET CT showing heterogenous marked tracer
uptake in the enlarged irregular prostate gland
FDG: fluorodeoxyglucose; PET: positron emission tomography; MIP: maximum intensity projection

Due to the case's complexity, pathology slides were sent for a second opinion. The final immunostaining
detected the SS18-SSX2 fusion gene consistent with a diagnosis of synovial sarcoma of the prostate. The
patient was started on chemotherapy on Adriamycin®, ifosfamide, and mesna (AIM) therapy with a plan to
repeat every 21 days; a total of six complete cycles.

Discussion
Synovial sarcoma is exceptionally uncommon and accounts for 5-10% of soft-tissue tumors. For every one
million people, only one to two are diagnosed with synovial sarcoma per year in the United States [9]. About
90% of synovial sarcomas occur on the extremities. In the genitourinary system, most synovial sarcomas
have been reported in the kidney [10].
Synovial sarcoma typically presents in young to middle-aged men. Most patient presents with increased
urinary frequency, hematuria, dysuria, and nocturia before urinary retention due to bladder outlet
obstruction. CT scan and MRI imaging modalities help stage tumor extent and plan surgical resection. MRI
is the modality of choice for the initial staging of synovial sarcoma because of the information provided by
intrinsic signal characteristics and superior soft-tissue contrast. MRI is also required to assess the extent and
inherent characteristics of the sarcoma. Diagnosis of synovial sarcoma of the prostate is mainly dependent
on histopathology and immunostaining of the mass. The SS18-SSX1 and SS18-SSX2 fusion genes are
exclusive in synovial sarcomas. Detection of these fusion genes confirms the diagnosis of synovial sarcoma
[11]. As in our case, prostate biopsy demonstrated spindle cell malignancy with immunostaining positive for
SS18-SSX2 fusion gene, confirming the diagnosis of synovial carcinoma of the prostate.
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Synovial sarcoma is a malignant and aggressive tumor with a poor prognosis [7]. It spreads either by systemic
spread or through local invasion. The mean survival is of 24 months despite multimodal treatment [12].
Prostate-specific antigen (PSA) is periodically monitored to see the treatment response in prostate
adenocarcinoma but has no role in prostate sarcomas. PSA levels are usually within normal limits in
synovial sarcoma of the prostate due to their non-epithelial origin [13]. Treatment of prostate sarcoma is
uncertain due to limited reported cases and experience, but it appears that aggressive resection must be
considered for the treatment of locally confined synovial sarcoma [6]. Other strategy includes surgical
resection with adjuvant chemotherapy and/or radiotherapy if external iliac, hypogastric, or distant lymph
nodes are involved because of its aggressive nature and poor prognosis [3,14].

Conclusions
The prostate is a rare and unusual location for the synovial sarcoma. Since the incidence of this sarcoma is
very rare, it can easily be misdiagnosed with BPH and adenocarcinoma of the prostate because of similar
signs and symptoms. We present this case to elevate the awareness about synovial sarcoma of the prostate; a
physician should always keep it as a differential diagnosis for prostate enlargement in young and middleaged men.
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